Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators

Neurosci Lett. 2007 Apr 24;417(1):1-5. doi: 10.1016/j.neulet.2007.01.017. Epub 2007 Jan 11.

Abstract

Plasminogen activators are used in thrombolytic stroke therapy. However, it is increasingly recognized that they have other actions besides fibrinolysis. In this study, we assess potential pro-inflammatory effects of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) in rat cortical astrocytes. Both uPA and tPA induced rapid dose-dependent upregulation in MMP-2 and MMP-9, as demonstrated by zymography of conditioned media. In addition, a multiplex ELISA array demonstrated that patterned responses in chemokines and cytokines were also evoked. Exposure to tPA induced elevations in secreted MIP-2, MCP-1 and GRO/KC. Exposure to uPA induced elevations in secreted IFN-gamma, TNF-alpha, GMCSF, MIP-1alpha, MIP-2, MIP-3alpha, MCP-1, RANTES and fractalkine. These data suggest that plasminogen activators may trigger selected pro-inflammatory responses at the neurovascular interface. Whether these effects influence thrombolytic stroke therapy warrants further investigation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Astrocytes / drug effects*
  • Astrocytes / immunology
  • Astrocytes / metabolism
  • Biomarkers / analysis
  • Biomarkers / metabolism
  • Blood-Brain Barrier / drug effects
  • Blood-Brain Barrier / immunology
  • Cells, Cultured
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / immunology
  • Cerebral Cortex / metabolism
  • Chemokines / immunology
  • Chemokines / metabolism
  • Cytokines / immunology
  • Cytokines / metabolism
  • Dose-Response Relationship, Drug
  • Encephalitis / chemically induced*
  • Encephalitis / immunology
  • Encephalitis / metabolism
  • Gliosis / chemically induced
  • Gliosis / immunology
  • Gliosis / metabolism
  • Inflammation Mediators / immunology*
  • Inflammation Mediators / metabolism*
  • Intracranial Thrombosis / drug therapy
  • Matrix Metalloproteinase 2 / drug effects
  • Matrix Metalloproteinase 2 / immunology
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 9 / drug effects
  • Matrix Metalloproteinase 9 / immunology
  • Matrix Metalloproteinase 9 / metabolism
  • Matrix Metalloproteinases / drug effects
  • Matrix Metalloproteinases / immunology
  • Matrix Metalloproteinases / metabolism
  • Plasminogen Activators / adverse effects*
  • Rats
  • Rats, Sprague-Dawley
  • Up-Regulation / drug effects
  • Up-Regulation / immunology

Substances

  • Biomarkers
  • Chemokines
  • Cytokines
  • Inflammation Mediators
  • Plasminogen Activators
  • Matrix Metalloproteinases
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9